Profile data is unavailable for this security.
About the company
Avid Bioservices, Inc. is a dedicated contract development and manufacturing organization (CDMO) focused on development and Current Good Manufacturing Practices (CGMP) manufacturing of biologics. The Company provides a comprehensive range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. Its services include CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. For early-stage programs the Company provides a variety of process development activities, including cell line development, upstream and downstream development and optimization, analytical methods development, testing and characterization. The scope of its services ranges from standalone process development projects to full development and manufacturing programs through commercialization. Commercial biologics produced by it are distributed to over 90 countries.
- Revenue in USD (TTM)142.36m
- Net income in USD-144.17m
- Incorporated1996
- Employees371.00
- LocationAvid Bioservices Inc14191 MYFORD ROADTUSTIN 92780United StatesUSA
- Phone+1 (714) 508-6100
- Fax+1 (714) 838-5817
- Websitehttps://avidbio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Emergent Biosolutions Inc | 1.13bn | -208.80m | 509.33m | 1.60k | -- | 1.00 | -- | 0.4525 | -4.10 | -4.10 | 21.19 | 9.40 | 0.6678 | 2.21 | 6.66 | 703,437.50 | -12.39 | -2.94 | -16.86 | -3.66 | 33.51 | 53.24 | -18.55 | -5.95 | 1.47 | -1.20 | 0.5658 | -- | -6.10 | 6.05 | -259.40 | -- | -4.29 | -- |
| SNDL Inc | 652.27m | -79.06m | 525.69m | 2.52k | -- | 0.6076 | -- | 0.8059 | -0.3017 | -0.3017 | 2.48 | 3.26 | 0.6062 | 4.98 | 36.38 | 259,248.20 | -7.61 | -24.44 | -8.22 | -27.94 | 25.69 | 22.49 | -12.55 | -62.17 | 4.16 | -- | 0.114 | -- | 27.63 | -- | 49.83 | -- | -- | -- |
| ASP Isotopes Inc | 2.30m | -27.05m | 548.67m | 76.00 | -- | 36.50 | -- | 239.00 | -0.628 | -0.628 | 0.0549 | 0.2112 | 0.068 | -- | -- | 30,206.32 | -71.81 | -- | -89.44 | -- | 36.54 | -- | -1,055.85 | -- | -- | -8.11 | 0.6748 | -- | -- | -- | -229.34 | -- | -- | -- |
| Eyepoint Pharmaceuticals Inc | 45.71m | -103.57m | 568.60m | 121.00 | -- | 2.04 | -- | 12.44 | -2.01 | -2.01 | 0.9018 | 4.09 | 0.1983 | 1.05 | 106.19 | 377,793.40 | -44.94 | -40.44 | -59.48 | -47.79 | 91.48 | 83.45 | -226.57 | -186.23 | 5.45 | -- | 0.00 | -- | 11.14 | -- | 30.77 | -- | -- | -- |
| CorMedix Inc | 12.26m | -46.15m | 626.80m | 82.00 | -- | 10.18 | -- | 51.12 | -0.8011 | -0.8011 | 0.212 | 1.01 | 0.1451 | -- | -- | 149,539.50 | -54.61 | -54.84 | -64.60 | -62.32 | 83.57 | 6.18 | -376.35 | -18,323.42 | 3.60 | -- | 0.00 | -- | -100.00 | -- | -56.02 | -- | 46.27 | -- |
| Sinovac Biotech Ltd | 429.20m | -130.73m | 639.90m | 3.04k | -- | -- | -- | 1.49 | -1.31 | -1.31 | 4.31 | 86.81 | 0.0322 | 0.2019 | 1.08 | 141,325.00 | -2.23 | 36.14 | -3.30 | 58.37 | 92.09 | 90.77 | -69.19 | 65.87 | 11.24 | -- | 0.0262 | -- | -69.97 | 14.31 | -198.16 | -- | 91.80 | -- |
| Phathom Pharmaceuticals Inc | 26.27m | -339.45m | 646.17m | 452.00 | -- | -- | -- | 24.60 | -5.69 | -5.69 | 0.4398 | -2.74 | 0.0842 | 2.68 | -- | 58,119.47 | -108.79 | -83.26 | -126.95 | -93.77 | 83.54 | -- | -1,292.14 | -135,982.00 | 5.68 | -5.60 | 1.56 | -- | -- | -- | -1.96 | -- | -- | -- |
| Elite Pharmaceuticals Inc | 71.17m | -6.39m | 659.87m | 64.00 | -- | 13.96 | -- | 9.27 | -0.0059 | -0.0059 | 0.0677 | 0.0443 | 0.8957 | 2.68 | 4.46 | 1,112,051.00 | -8.04 | 19.07 | -10.06 | 24.29 | 44.73 | 46.63 | -8.98 | 20.77 | 2.42 | 0.75 | 0.1634 | 0.00 | 65.79 | 49.55 | 464.56 | -- | 111.50 | -- |
| Pliant Therapeutics Inc | 0.00 | -201.68m | 781.97m | 158.00 | -- | 2.26 | -- | -- | -3.34 | -3.34 | 0.00 | 5.68 | 0.00 | -- | -- | 0.00 | -40.90 | -33.24 | -43.90 | -35.39 | -- | -- | -- | -360.29 | -- | -- | 0.0802 | -- | -83.69 | -- | -30.83 | -- | -16.89 | -- |
| Avid Bioservices Inc | 142.36m | -144.17m | 783.46m | 371.00 | -- | 13.33 | -- | 5.50 | -2.27 | -2.27 | 2.24 | 0.9192 | 0.3661 | 3.81 | 4.32 | 383,714.30 | -37.08 | -0.826 | -57.59 | -1.20 | 6.27 | 19.26 | -101.27 | -2.14 | 1.05 | -3.18 | 0.7343 | -- | -6.27 | 21.15 | -54,444.79 | -- | 84.15 | -- |
| Pacira Biosciences Inc | 694.96m | -90.73m | 802.49m | 711.00 | -- | 1.07 | -- | 1.15 | -2.15 | -2.15 | 13.03 | 16.24 | 0.4548 | 1.71 | 7.03 | 977,436.00 | -5.94 | 3.35 | -6.83 | 3.98 | 74.35 | 72.63 | -13.06 | 8.57 | 1.89 | -- | 0.4393 | 0.00 | 1.22 | 14.88 | 163.72 | -- | 0.8761 | -- |
| Evolus Inc | 248.33m | -55.46m | 825.71m | 322.00 | -- | 140.03 | -- | 3.33 | -0.9141 | -0.9141 | 4.11 | 0.0931 | 1.25 | 4.59 | 6.61 | 909,619.10 | -27.90 | -40.92 | -38.48 | -59.74 | 69.94 | 65.43 | -22.33 | -80.46 | 2.23 | -2.04 | 0.9537 | -- | 35.98 | -- | 17.10 | -- | 182.77 | -- |
| Liquidia Corp | 15.61m | -119.48m | 852.59m | 136.00 | -- | 7.76 | -- | 54.62 | -1.62 | -1.62 | 0.2111 | 1.31 | 0.0857 | -- | 4.14 | 114,779.40 | -65.55 | -55.02 | -75.02 | -62.69 | 64.65 | 82.18 | -765.37 | -474.59 | 6.33 | -31.14 | 0.5059 | -- | 9.75 | 45.23 | -91.40 | -- | 66.93 | -- |
| Phibro Animal Health Corp | 1.05bn | 17.41m | 962.37m | 1.94k | 55.35 | 3.72 | 17.92 | 0.9194 | 0.4293 | 0.4293 | 25.82 | 6.38 | 1.08 | 2.60 | 6.75 | 539,568.10 | 1.80 | 3.93 | 2.20 | 4.90 | 31.47 | 31.18 | 1.66 | 3.77 | 1.69 | 2.20 | 0.6472 | 56.45 | 4.07 | 4.21 | -92.59 | -46.35 | 6.65 | 0.8548 |
| Collegium Pharmaceutical Inc | 599.25m | 88.59m | 980.73m | 197.00 | 15.21 | 4.18 | 4.14 | 1.64 | 2.00 | 2.00 | 13.05 | 7.27 | 0.4261 | 6.25 | 2.92 | 3,041,853.00 | 6.30 | 2.79 | 9.38 | 4.80 | 62.36 | 50.88 | 14.78 | 5.16 | 0.8832 | 3.94 | 0.7873 | 0.00 | 22.17 | 15.11 | 292.60 | -- | -54.77 | -- |
Data as of Nov 22 2024. Currency figures normalised to Avid Bioservices Inc's reporting currency: US Dollar USD
50.93%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Point72 Asset Management LPas of 30 Sep 2024 | 4.86m | 7.62% |
| BlackRock Fund Advisorsas of 30 Sep 2024 | 4.57m | 7.17% |
| AltraVue Capital LLCas of 30 Sep 2024 | 3.80m | 5.95% |
| The Vanguard Group, Inc.as of 30 Sep 2024 | 3.68m | 5.77% |
| SSgA Funds Management, Inc.as of 30 Sep 2024 | 3.00m | 4.71% |
| Punch & Associates Investment Management, Inc.as of 30 Sep 2024 | 2.93m | 4.60% |
| RBC Global Asset Management (US), Inc.as of 30 Sep 2024 | 2.82m | 4.42% |
| First Light Asset Management LLCas of 30 Sep 2024 | 2.77m | 4.35% |
| Portolan Capital Management LLCas of 30 Sep 2024 | 2.09m | 3.28% |
| Palisade Capital Management LPas of 30 Sep 2024 | 1.96m | 3.08% |
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
